Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (3,081)	$ (72,647)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(999)
Payment made on behalf of the SPAC by related party	3,081	4,688
Changes in operating assets and liabilities:
Prepaid expenses		(334,604)
Accrued expenses		(40,630)
Net cash used in operating activities		(444,192)
Cash flows from investing activities:
Principal deposited in Trust Account		(174,225,000)
Net cash used in investing activities		(174,225,000)
Cash flows from financing activities:
Proceeds from Initial Public Offering, net of underwriters’ fees		169,050,000
Proceeds from representative shares
Proceeds from private placement		6,675,000
Proceeds from issuance of promissory note to related party		225,000
Repayment of promissory note to related party		(379,317)
Payment of deferred offering costs		(373,001)
Net cash provided by financing activities		175,197,682
Net change in cash		528,490
Cash, beginning of the period		11,120
Cash, end of the period		539,610
Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting commissions charged to additional paid in capital		6,037,500
Due from related party		50,000
Accretion of carrying value of Class A stock to redemption value		$ 30,815,451